 | • レポートコード：GIR201114055 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、COPD治療薬の世界市場を調査対象にし、COPD治療薬の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（気管支拡張剤、PDE-4阻害剤、ステロイド、併用療法、その他）、用途別分析（病院、クリニック、その他）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：Pfizer、Roche Holding AG、Merck、Novartis、AstraZeneca、GlaxoSmithKline、Vectura Group、Boehringer Ingelheim、Abbott Laboratories、Teva Pharmaceutical Industries、Mylan NV ・企業別売上、市場シェア ・COPD治療薬の地域別市場分析 ・COPD治療薬の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・COPD治療薬のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・COPD治療薬のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・COPD治療薬の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・COPD治療薬の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・COPD治療薬の種類別市場規模2015-2020：気管支拡張剤、PDE-4阻害剤、ステロイド、併用療法、その他 ・COPD治療薬の用途別市場規模2015-2020：病院、クリニック、その他 ・COPD治療薬の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論 |
Market Overview
The global COPD Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The COPD Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
COPD Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, COPD Drugs market has been segmented into:
Bronchodilators
PDE-4 Inhibitors
Steroids
Combination Therapies
Others
By Application, COPD Drugs has been segmented into:
Hospitals
Clinics
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global COPD Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level COPD Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global COPD Drugs market.
The report offers in-depth assessment of the growth and other aspects of the COPD Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and COPD Drugs Market Share Analysis
COPD Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, COPD Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the COPD Drugs sales, revenue and market share for each player covered in this report.
The major players covered in COPD Drugs are:
Pfizer
Roche Holding AG
Merck
Novartis
AstraZeneca
GlaxoSmithKline
Vectura Group
Boehringer Ingelheim
Abbott Laboratories
Teva Pharmaceutical Industries
Mylan NV
Table of Contents
1 COPD Drugs Market Overview
1.1 Product Overview and Scope of COPD Drugs
1.2 Classification of COPD Drugs by Type
1.2.1 Global COPD Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global COPD Drugs Revenue Market Share by Type in 2019
1.2.3 Bronchodilators
1.2.4 PDE-4 Inhibitors
1.2.5 Steroids
1.2.6 Combination Therapies
1.2.7 Others
1.3 Global COPD Drugs Market by Application
1.3.1 Overview: Global COPD Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global COPD Drugs Market by Regions
1.4.1 Global COPD Drugs Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of COPD Drugs (2015-2025)
1.4.3 North America (USA, Canada and Mexico) COPD Drugs Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) COPD Drugs Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) COPD Drugs Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) COPD Drugs Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) COPD Drugs Status and Prospect (2015-2025)
2 Company Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer SWOT Analysis
2.1.4 Pfizer Product and Services
2.1.5 Pfizer COPD Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.2 Roche Holding AG
2.2.1 Roche Holding AG Details
2.2.2 Roche Holding AG Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Roche Holding AG SWOT Analysis
2.2.4 Roche Holding AG Product and Services
2.2.5 Roche Holding AG COPD Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.3 Merck
2.3.1 Merck Details
2.3.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Merck SWOT Analysis
2.3.4 Merck Product and Services
2.3.5 Merck COPD Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novartis SWOT Analysis
2.4.4 Novartis Product and Services
2.4.5 Novartis COPD Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.5 AstraZeneca
2.5.1 AstraZeneca Details
2.5.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 AstraZeneca SWOT Analysis
2.5.4 AstraZeneca Product and Services
2.5.5 AstraZeneca COPD Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.6 GlaxoSmithKline
2.6.1 GlaxoSmithKline Details
2.6.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 GlaxoSmithKline SWOT Analysis
2.6.4 GlaxoSmithKline Product and Services
2.6.5 GlaxoSmithKline COPD Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.7 Vectura Group
2.7.1 Vectura Group Details
2.7.2 Vectura Group Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Vectura Group SWOT Analysis
2.7.4 Vectura Group Product and Services
2.7.5 Vectura Group COPD Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.8 Boehringer Ingelheim
2.8.1 Boehringer Ingelheim Details
2.8.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Boehringer Ingelheim SWOT Analysis
2.8.4 Boehringer Ingelheim Product and Services
2.8.5 Boehringer Ingelheim COPD Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.9 Abbott Laboratories
2.9.1 Abbott Laboratories Details
2.9.2 Abbott Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Abbott Laboratories SWOT Analysis
2.9.4 Abbott Laboratories Product and Services
2.9.5 Abbott Laboratories COPD Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.10 Teva Pharmaceutical Industries
2.10.1 Teva Pharmaceutical Industries Details
2.10.2 Teva Pharmaceutical Industries Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Teva Pharmaceutical Industries SWOT Analysis
2.10.4 Teva Pharmaceutical Industries Product and Services
2.10.5 Teva Pharmaceutical Industries COPD Drugs Revenue, Gross Margin and Market Share (2018-2019)
2.11 Mylan NV
2.11.1 Mylan NV Details
2.11.2 Mylan NV Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Mylan NV SWOT Analysis
2.11.4 Mylan NV Product and Services
2.11.5 Mylan NV COPD Drugs Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global COPD Drugs Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 COPD Drugs Players Market Share
3.2.2 Top 10 COPD Drugs Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global COPD Drugs Revenue and Market Share by Regions
4.2 North America COPD Drugs Revenue and Growth Rate (2015-2020)
4.3 Europe COPD Drugs Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific COPD Drugs Revenue and Growth Rate (2015-2020)
4.5 South America COPD Drugs Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa COPD Drugs Revenue and Growth Rate (2015-2020)
5 North America COPD Drugs Revenue by Countries
5.1 North America COPD Drugs Revenue by Countries (2015-2020)
5.2 USA COPD Drugs Revenue and Growth Rate (2015-2020)
5.3 Canada COPD Drugs Revenue and Growth Rate (2015-2020)
5.4 Mexico COPD Drugs Revenue and Growth Rate (2015-2020)
6 Europe COPD Drugs Revenue by Countries
6.1 Europe COPD Drugs Revenue by Countries (2015-2020)
6.2 Germany COPD Drugs Revenue and Growth Rate (2015-2020)
6.3 UK COPD Drugs Revenue and Growth Rate (2015-2020)
6.4 France COPD Drugs Revenue and Growth Rate (2015-2020)
6.5 Russia COPD Drugs Revenue and Growth Rate (2015-2020)
6.6 Italy COPD Drugs Revenue and Growth Rate (2015-2020)
7 Asia-Pacific COPD Drugs Revenue by Countries
7.1 Asia-Pacific COPD Drugs Revenue by Countries (2015-2020)
7.2 China COPD Drugs Revenue and Growth Rate (2015-2020)
7.3 Japan COPD Drugs Revenue and Growth Rate (2015-2020)
7.4 Korea COPD Drugs Revenue and Growth Rate (2015-2020)
7.5 India COPD Drugs Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia COPD Drugs Revenue and Growth Rate (2015-2020)
8 South America COPD Drugs Revenue by Countries
8.1 South America COPD Drugs Revenue by Countries (2015-2020)
8.2 Brazil COPD Drugs Revenue and Growth Rate (2015-2020)
8.3 Argentina COPD Drugs Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue COPD Drugs by Countries
9.1 Middle East & Africa COPD Drugs Revenue by Countries (2015-2020)
9.2 Saudi Arabia COPD Drugs Revenue and Growth Rate (2015-2020)
9.3 UAE COPD Drugs Revenue and Growth Rate (2015-2020)
9.4 Egypt COPD Drugs Revenue and Growth Rate (2015-2020)
9.5 South Africa COPD Drugs Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global COPD Drugs Revenue and Market Share by Type (2015-2020)
10.2 Global COPD Drugs Market Forecast by Type (2019-2024)
10.3 Bronchodilators Revenue Growth Rate (2015-2025)
10.4 PDE-4 Inhibitors Revenue Growth Rate (2015-2025)
10.5 Steroids Revenue Growth Rate (2015-2025)
10.6 Combination Therapies Revenue Growth Rate (2015-2025)
10.7 Others Revenue Growth Rate (2015-2025)
11 Global COPD Drugs Market Segment by Application
11.1 Global COPD Drugs Revenue Market Share by Application (2015-2020)
11.2 COPD Drugs Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Clinics Revenue Growth (2015-2020)
11.5 Others Revenue Growth (2015-2020)
12 Global COPD Drugs Market Size Forecast (2021-2025)
12.1 Global COPD Drugs Market Size Forecast (2021-2025)
12.2 Global COPD Drugs Market Forecast by Regions (2021-2025)
12.3 North America COPD Drugs Revenue Market Forecast (2021-2025)
12.4 Europe COPD Drugs Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific COPD Drugs Revenue Market Forecast (2021-2025)
12.6 South America COPD Drugs Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa COPD Drugs Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global COPD Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of COPD Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global COPD Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market COPD Drugs Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Pfizer Corporate Information, Location and Competitors
Table 6. Pfizer COPD Drugs Major Business
Table 7. Pfizer COPD Drugs Total Revenue (USD Million) (2017-2018)
Table 8. Pfizer SWOT Analysis
Table 9. Pfizer COPD Drugs Product and Solutions
Table 10. Pfizer COPD Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Roche Holding AG Corporate Information, Location and Competitors
Table 12. Roche Holding AG COPD Drugs Major Business
Table 13. Roche Holding AG COPD Drugs Total Revenue (USD Million) (2018-2019)
Table 14. Roche Holding AG SWOT Analysis
Table 15. Roche Holding AG COPD Drugs Product and Solutions
Table 16. Roche Holding AG COPD Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Merck Corporate Information, Location and Competitors
Table 18. Merck COPD Drugs Major Business
Table 19. Merck COPD Drugs Total Revenue (USD Million) (2017-2018)
Table 20. Merck SWOT Analysis
Table 21. Merck COPD Drugs Product and Solutions
Table 22. Merck COPD Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. Novartis Corporate Information, Location and Competitors
Table 24. Novartis COPD Drugs Major Business
Table 25. Novartis COPD Drugs Total Revenue (USD Million) (2017-2018)
Table 26. Novartis SWOT Analysis
Table 27. Novartis COPD Drugs Product and Solutions
Table 28. Novartis COPD Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. AstraZeneca Corporate Information, Location and Competitors
Table 30. AstraZeneca COPD Drugs Major Business
Table 31. AstraZeneca COPD Drugs Total Revenue (USD Million) (2017-2018)
Table 32. AstraZeneca SWOT Analysis
Table 33. AstraZeneca COPD Drugs Product and Solutions
Table 34. AstraZeneca COPD Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. GlaxoSmithKline Corporate Information, Location and Competitors
Table 36. GlaxoSmithKline COPD Drugs Major Business
Table 37. GlaxoSmithKline COPD Drugs Total Revenue (USD Million) (2017-2018)
Table 38. GlaxoSmithKline SWOT Analysis
Table 39. GlaxoSmithKline COPD Drugs Product and Solutions
Table 40. GlaxoSmithKline COPD Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Vectura Group Corporate Information, Location and Competitors
Table 42. Vectura Group COPD Drugs Major Business
Table 43. Vectura Group COPD Drugs Total Revenue (USD Million) (2017-2018)
Table 44. Vectura Group SWOT Analysis
Table 45. Vectura Group COPD Drugs Product and Solutions
Table 46. Vectura Group COPD Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. Boehringer Ingelheim Corporate Information, Location and Competitors
Table 48. Boehringer Ingelheim COPD Drugs Major Business
Table 49. Boehringer Ingelheim COPD Drugs Total Revenue (USD Million) (2017-2018)
Table 50. Boehringer Ingelheim SWOT Analysis
Table 51. Boehringer Ingelheim COPD Drugs Product and Solutions
Table 52. Boehringer Ingelheim COPD Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. Abbott Laboratories Corporate Information, Location and Competitors
Table 54. Abbott Laboratories COPD Drugs Major Business
Table 55. Abbott Laboratories COPD Drugs Total Revenue (USD Million) (2017-2018)
Table 56. Abbott Laboratories SWOT Analysis
Table 57. Abbott Laboratories COPD Drugs Product and Solutions
Table 58. Abbott Laboratories COPD Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. Teva Pharmaceutical Industries Corporate Information, Location and Competitors
Table 60. Teva Pharmaceutical Industries COPD Drugs Major Business
Table 61. Teva Pharmaceutical Industries COPD Drugs Total Revenue (USD Million) (2017-2018)
Table 62. Teva Pharmaceutical Industries SWOT Analysis
Table 63. Teva Pharmaceutical Industries COPD Drugs Product and Solutions
Table 64. Teva Pharmaceutical Industries COPD Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Mylan NV Corporate Information, Location and Competitors
Table 66. Mylan NV COPD Drugs Major Business
Table 67. Mylan NV COPD Drugs Total Revenue (USD Million) (2017-2018)
Table 68. Mylan NV SWOT Analysis
Table 69. Mylan NV COPD Drugs Product and Solutions
Table 70. Mylan NV COPD Drugs Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 71. Global COPD Drugs Revenue (Million USD) by Players (2015-2020)
Table 72. Global COPD Drugs Revenue Share by Players (2015-2020)
Table 73. Global COPD Drugs Revenue (Million USD) by Regions (2015-2020)
Table 74. Global COPD Drugs Revenue Market Share by Regions (2015-2020)
Table 75. North America COPD Drugs Revenue by Countries (2015-2020)
Table 76. North America COPD Drugs Revenue Market Share by Countries (2015-2020)
Table 77. Europe COPD Drugs Revenue (Million USD) by Countries (2015-2020)
Table 78. Asia-Pacific COPD Drugs Revenue (Million USD) by Countries (2015-2020)
Table 79. South America COPD Drugs Revenue by Countries (2015-2020)
Table 80. South America COPD Drugs Revenue Market Share by Countries (2015-2020)
Table 81. Middle East and Africa COPD Drugs Revenue (Million USD) by Countries (2015-2020)
Table 82. Middle East and Africa COPD Drugs Revenue Market Share by Countries (2015-2020)
Table 83. Global COPD Drugs Revenue (Million USD) by Type (2015-2020)
Table 84. Global COPD Drugs Revenue Share by Type (2015-2020)
Table 85. Global COPD Drugs Revenue Forecast by Type (2021-2025)
Table 86. Global COPD Drugs Revenue by Application (2015-2020)
Table 87. Global COPD Drugs Revenue Share by Application (2015-2020)
Table 88. Global COPD Drugs Revenue Forecast by Application (2021-2025)
Table 89. Global COPD Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. COPD Drugs Picture
Figure 2. Global COPD Drugs Revenue Market Share by Type in 2019
Figure 3. Bronchodilators Picture
Figure 4. PDE-4 Inhibitors Picture
Figure 5. Steroids Picture
Figure 6. Combination Therapies Picture
Figure 7. Others Picture
Figure 8. COPD Drugs Revenue Market Share by Application in 2019
Figure 9. Hospitals Picture
Figure 10. Clinics Picture
Figure 11. Others Picture
Figure 12. Global COPD Drugs Revenue (USD Million) and Growth Rate (2015-2025)
Figure 13. North America COPD Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Europe COPD Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Asia-Pacific COPD Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. South America COPD Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Middle East and Africa COPD Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 18. Global COPD Drugs Revenue (Million USD) and Growth Rate (2015-2025)
Figure 19. Global COPD Drugs Revenue Share by Players in 2019
Figure 20. Global Top 5 Players COPD Drugs Revenue Market Share in 2019
Figure 21. Global Top 10 Players COPD Drugs Revenue Market Share in 2019
Figure 22. Key Players Market Share Trend
Figure 23. Global COPD Drugs Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 24. Global COPD Drugs Revenue Market Share by Regions (2015-2020)
Figure 25. Global COPD Drugs Revenue Market Share by Regions in 2018
Figure 26. North America COPD Drugs Revenue and Growth Rate (2015-2020)
Figure 27. Europe COPD Drugs Revenue and Growth Rate (2015-2020)
Figure 28. Asia-Pacific COPD Drugs Revenue and Growth Rate (2015-2020)
Figure 29. South America COPD Drugs Revenue and Growth Rate (2015-2020)
Figure 30. Middle East and Africa COPD Drugs Revenue and Growth Rate (2015-2020)
Figure 31. North America COPD Drugs Revenue Market Share by Countries (2015-2020)
Figure 32. North America COPD Drugs Revenue Market Share by Countries in 2019
Figure 33. USA COPD Drugs Revenue and Growth Rate (2015-2020)
Figure 34. Canada COPD Drugs Revenue and Growth Rate (2015-2020)
Figure 35. Mexico COPD Drugs Revenue and Growth Rate (2015-2020)
Figure 36. Europe COPD Drugs Revenue Market Share by Countries (2015-2020)
Figure 37. Europe COPD Drugs Revenue Market Share by Countries in 2019
Figure 38. Germany COPD Drugs Revenue and Growth Rate (2015-2020)
Figure 39. UK COPD Drugs Revenue and Growth Rate (2015-2020)
Figure 40. France COPD Drugs Revenue and Growth Rate (2015-2020)
Figure 41. Russia COPD Drugs Revenue and Growth Rate (2015-2020)
Figure 42. Italy COPD Drugs Revenue and Growth Rate (2015-2020)
Figure 43. Asia-Pacific COPD Drugs Revenue Market Share by Countries (2015-2020)
Figure 44. Asia-Pacific COPD Drugs Revenue Market Share by Countries in 2019
Figure 45. China COPD Drugs Revenue and Growth Rate (2015-2020)
Figure 46. Japan COPD Drugs Revenue and Growth Rate (2015-2020)
Figure 47. Korea COPD Drugs Revenue and Growth Rate (2015-2020)
Figure 48. India COPD Drugs Revenue and Growth Rate (2015-2020)
Figure 49. Southeast Asia COPD Drugs Revenue and Growth Rate (2015-2020)
Figure 50. South America COPD Drugs Revenue Market Share by Countries (2015-2020)
Figure 51. South America COPD Drugs Revenue Market Share by Countries in 2019
Figure 52. Brazil COPD Drugs Revenue and Growth Rate (2015-2020)
Figure 53. Argentina COPD Drugs Revenue and Growth Rate (2015-2020)
Figure 54. Middle East and Africa COPD Drugs Revenue Market Share by Countries (2015-2020)
Figure 55. Middle East and Africa COPD Drugs Revenue Market Share by Countries in 2019
Figure 56. Saudi Arabia COPD Drugs Revenue and Growth Rate (2015-2020)
Figure 57. UAE COPD Drugs Revenue and Growth Rate (2015-2020)
Figure 58. Egypt COPD Drugs Revenue and Growth Rate (2015-2020)
Figure 59. South Africa COPD Drugs Revenue and Growth Rate (2015-2020)
Figure 60. Global COPD Drugs Revenue Share by Type (2015-2020)
Figure 61. Global COPD Drugs Revenue Share by Type in 2019
Figure 62. Global COPD Drugs Market Share Forecast by Type (2021-2025)
Figure 63. Global Bronchodilators Revenue Growth Rate (2015-2020)
Figure 64. Global PDE-4 Inhibitors Revenue Growth Rate (2015-2020)
Figure 65. Global Steroids Revenue Growth Rate (2015-2020)
Figure 66. Global Combination Therapies Revenue Growth Rate (2015-2020)
Figure 67. Global Others Revenue Growth Rate (2015-2020)
Figure 68. Global COPD Drugs Revenue Share by Application (2015-2020)
Figure 69. Global COPD Drugs Revenue Share by Application in 2019
Figure 70. Global COPD Drugs Market Share Forecast by Application (2021-2025)
Figure 71. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 72. Global Clinics Revenue Growth Rate (2015-2020)
Figure 73. Global Others Revenue Growth Rate (2015-2020)
Figure 74. Global COPD Drugs Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 75. Global COPD Drugs Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 76. Global COPD Drugs Revenue Market Share Forecast by Regions (2021-2025)
Figure 77. North America COPD Drugs Revenue Market Forecast (2021-2025)
Figure 78. Europe COPD Drugs Revenue Market Forecast (2021-2025)
Figure 79. Asia-Pacific COPD Drugs Revenue Market Forecast (2021-2025)
Figure 80. South America COPD Drugs Revenue Market Forecast (2021-2025)
Figure 81. Middle East and Africa COPD Drugs Revenue Market Forecast (2021-2025)
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
COPD用粘液クリアランスデバイスの世界市場 2020年 Market Overview The global Mucus Clearance Devices for COPD market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Mucus Cleara…- COPD・喘息デバイスの世界市場 2020年 Market Overview The global COPD and Asthma Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The COPD and Asthma Devic…
- 吸入及び点鼻薬ジェネリック医薬品の世界市場 2020年 Market Overview The Inhalation & Nasal Spray Generic Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value ch…
- エクセナチド薬の世界市場 2020年 Market Overview The global Exenatide Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Exenatide Drugs market report…
- テデュグルチド薬の世界市場 2020年 Market Overview The global Teduglutide Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Teduglutide Drugs market re…